Ozempic is the brand name for semaglutide, a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus in adults
It can help people lose modest amounts of weight
The evolving landscape of non-invasive treatments, including MRI-guided focused ultrasound and radiofrequency ablation, offers promising options that can preserve the uterus and improve quality of life, but more research is needed to establish their long-term efficacy
Until that point, its use outside of approved clinical trials is not sanctioned by UK regulatory authorities, and the risks of self-administration particularly involving home reconstitution of an unregulated product far outweigh any potential benefit
Was medication stopped, reduced, delayed, or changed